NCT03836690View on ClinicalTrials.gov

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

April 1, 2023

Conditions
LymphomaLeukemiaMyelomaMyelodysplastic SyndromesSevere Aplastic AnemiaPrimary Immune DeficiencyGraft Vs Host Disease
Interventions
BIOLOGICAL

CD62L- Tem

Donor memory T cells that have been depleted of CD62L+

Trial Locations (1)

Unknown

RECRUITING

UCLH, London

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University College, London

OTHER

NCT03836690 - Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter